Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: The characteristics of androgen receptor splice variant 7 in the treatment of hormonal sensitive prostate cancer: a systematic review and meta-analysis

Fig. 2

Forest plots of AR-V7-positive proportion in newly diagnosed PCa and CRPC from fifteen studies. AR-V7-positive proportion in newly diagnosed PCa and CRPC were calculated using random-effect models. Subgroup analyses were performed based on various AR-V7 detection assays. The bars indicate 95% CIs. AR-V7 androgen receptor splicing variant 7, CRPC castration-resistant prostate cancer, PCa prostate cancer, CI confidence interval, OR odds ratio, CTC circulating tumor cell, RISH RNA in situ hybridization, IHC immunohistochemistry, ctRNA circulating tumor RNA

Back to article page